Company To Stop Selling Inhaled Insulin

iVillage Member
Registered: 08-07-2007
Company To Stop Selling Inhaled Insulin
Tue, 10-30-2007 - 12:00pm

Oct. 26 (iVillage Total Health) – Poor sales may mean the end of Exubera, the first and only brand of inhaled insulin available.


Marketed by Pfizer Inc., the product was launched only last summer, after years of research and publicity. Inhaled insulin had been described by the U.S. Food and Drug Administration as the biggest advance in insulin therapy since insulin’s discovery in the 1920s.


However, some patients and doctors have complained that the oral inhaler was too big and inconvenient and that insurance companies resisted covering the recommended periodic lung tests. And some patients reported being embarrassed to use the device in public because of its resemblance to a “bong” – a device used to smoke marijuana.


Read Article






    Photo Sharing and Video Hosting at Photobucket









October is Breast Cancer Awareness month.
In the Loop features famous landmarks lit up in pink, beautiful! Visit Breast Cancer Support on iVillage Total Health